Argent Biopharma (LSE: RGT)

Last close As at 20/12/2024

GBP0.07

1.00 (18.18%)

Market capitalisation

GBP4m

Argent Biopharma is an Australia-headquartered specialist medical cannabis biopharma company, which has most of its operations based in Europe.

Latest Insights

View More

Healthcare | Update

Argent Biopharma — Valuation report

Healthcare | QuickView

Argent Biopharma — An innovative approach to drug development

Sector

Healthcare

Equity Analyst

Jyoti Prakash

Jyoti Prakash

Analyst, Healthcare

Arron Aatkar

Analyst

Key Management

  • Igor Bluvstein

    CFO

  • Roby Zomer

    Managing Director and Co-CEO

  • Yifat Steuer

    COO

Thematics

thematic

Healthcare

Healthcare-focused trusts: A sector on the mend

thematic

Healthcare

Deutsches Eigenkapitalforum (EKF) 2023 healthcare

volition01

thematic

Healthcare

VolitionRx – Decoding the DNA of cancer 

Subscribe to Edison

Get access to the very latest content matched to your personal investment style.

Sign up for free